NEURONES: Organic growth up 5.1% over the first nine months of 2018
November 07 2018 - 10:40AM
PRESS INFORMATION
Heading: 3rd quarter 2018
Revenues
Nanterre, November 7, 2018 (after the closing of
the stock exchange)
Organic growth up
5.1% over the first nine months of 2018
(unaudited,
in euro millions) |
2017
published |
2017 restated
IFRS 15 |
2018 |
growth with
iso-method |
of which organic |
|
3rd quarter
revenues |
114 |
112.3 |
116.9 |
+ 4.1% |
+ 5.2% |
| Total at
end of September |
359 |
351.4 |
360 |
+ 2.4% |
+ 5.1% |
Achievements
On an identical scope and
accounting method (IFRS 15) basis, the business activity grew 5.1%
over the first 9 months of FY2018. It was very dynamic in
cybersecurity, DevOps platforms, infrastructure automation,
mobility, EDM and RPA type applications and digital transformation
consulting.
The 3rd quarter
operating margin (*) was 9.9%.
Over the first nine months, it was
8.9% of revenues (as in 2017).
(*) Unaudited and after expenses of 0.3% related
to bonus shares.
Outlook
For the entire 2018 fiscal year,
NEURONES maintains its forecast of more than €490 million in
revenues (IFRS 15). Operating profit is forecast at a minimum of 9%
of revenues.
About
NEURONES
With 5,200 experts, the NEURONES
group specializes in Consulting (Management, Organization and
Digital) and IT Services (Infrastructures and Applications). It
supports its clients in their digital transformation projects and
in the upgrading their information systems.
Euronext Paris (compartment B -
NRO) - Enternext Tech 40 - SRD medium values
www.neurones.net
Press Relations:
Florence Gillier Communication
Sabine Grosdidier
Tel: +33 (0)1 41 18 85 55
sabineg@fgcom.fr |
NEURONES
Matthieu Vautier
Tel: +33 (0)1 41 37 41 37
rp@neurones.net |
Investor Relations:
NEURONES
Paul-César Bonnel
Tel: +33 (0)1 41 37 41 37
investisseurs@neurones.net |
neurones-communique-press-release-Q3-2018-revenues
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: NEURONES via Globenewswire
Neurones (EU:NRO)
Historical Stock Chart
From Feb 2025 to Mar 2025
Neurones (EU:NRO)
Historical Stock Chart
From Mar 2024 to Mar 2025
